CASK Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93, a CaMKII inhibitor, indirectly influences CASK by modulating calcium signaling. CaMKII regulates CASK expression, and KN-93 inhibits this regulation, resulting in altered CASK activity through the modulation of calcium-dependent signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, indirectly affects CASK by suppressing the MAPK pathway. CASK interacts with components of the MAPK cascade, and U0126 disrupts this pathway, leading to downstream effects that influence CASK function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, indirectly modulates CASK by interfering with the PI3K/Akt pathway. CASK interacts with Akt, and Wortmannin disrupts this pathway, resulting in altered CASK activity through the modulation of PI3K-dependent signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, indirectly affects CASK by suppressing the p38 MAPK pathway. CASK interacts with components of this pathway, and SB203580 disrupts it, resulting in altered CASK activity through the modulation of p38 MAPK-dependent signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, indirectly modulates CASK by suppressing the JNK signaling pathway. CASK interacts with JNK, and SP600125 disrupts this pathway, leading to downstream effects that influence CASK function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly influences CASK by interfering with the PI3K/Akt pathway. CASK interacts with Akt, and LY294002 disrupts this pathway, resulting in altered CASK activity through the modulation of PI3K-dependent signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, indirectly affects CASK by suppressing the MAPK pathway. CASK interacts with components of the MAPK cascade, and PD98059 disrupts this pathway, leading to downstream effects that influence CASK function. | ||||||
H-1152 dihydrochloride | 451462-58-1 | sc-203592 sc-203592A | 1 mg 5 mg | $104.00 $364.00 | 7 | |
H1152, a ROCK inhibitor, indirectly modulates CASK by suppressing the Rho/ROCK pathway. CASK interacts with ROCK, and H1152 disrupts this pathway, resulting in altered CASK activity through the modulation of Rho/ROCK-dependent signaling pathways. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662, an AMPK activator, indirectly influences CASK by modulating AMPK-dependent pathways. CASK is connected to AMPK signaling, and A769662 activates AMPK, leading to downstream effects that influence CASK function. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763, a GSK-3 inhibitor, indirectly affects CASK by modulating the Wnt/β-catenin pathway. CASK interacts with GSK-3, and SB216763 disrupts this pathway, resulting in altered CASK activity through the modulation of Wnt/β-catenin-dependent signaling pathways. | ||||||